This Week in Cancer Research | GenomeWeb

This Week in Cancer Research

Premium

In Cancer Research this week, researchers in China write that genetic variation in an miRNA-1827 binding site in the MYCL1 gene alters susceptibility to lung cancer. The researchers took an in silico approach to identifying SNPs within the 3′ UTR of miRNA genes that are deregulated in human small-cell lung cancer, and then looked at the possible associations between those SNPs and lung cancer susceptibility in 666 patients and 758 controls.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.